In vitro comparison of inhibitors of inducible nitric oxide synthase in a macrophage model

Journal of Extra-Corporeal Technology

Volumn 32, Issue 4, 2000, Pages 190-195

  Sanders, K ^a   Hunter, D B ^a   Larson, D F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Inductible nitric oxide synthase; Macrophage; Nitric oxide

Indexed keywords

ALCOHOL; ARGININE; CITRULLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; S METHYLPSEUDOTHIOUREA; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INACTIVATION; ENZYME INDUCTION; HEART FUNCTION; HYPOTENSION; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SECOND MESSENGER;

EID: 0034541570     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nitric oxide reduces depolarization-induced calcium influx in PC12 cells by a cyclic GMP-mediated mechanism
2. Nitric oxide production regulates cGMP formation and calcium influx in pancreatic acinar cells
3. Endogenous nitric oxide blocks calcium influx induced by glutamate in neurons containing NADPH diaphorase
4. Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo: A possible role for lipocortin 1
5. Differences in the effects of dexamethasone on macrophage nitrite production: Dependence on exposure regimen (in vivo or in vitro) and activation stimuli
6. Differential effects of in vivo ethanol on LPS-induced TNF and nitric oxide production in the lung
7. Independent suppression of nitric oxide and TNF alpha in the lung of conscious rats by ethanol
8. Effect of cardiopulmonary bypass on cytokine release and adhesion molecule expression in alveolar macrophages. Preliminary report in six cases
9. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass
10. Down-regulation of surface monocyte lipopolysaccharide-receptor CD14 in patients on cardiopulmonary bypass undergoing aortacoronary bypass operation
11. Tumor necrosis factor challenges in canines: Patterns of cardiovascular dysfunction
12. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock
13. Interleukin-1beta causes different levels of nitric oxide-mediated depression of contractility in different positions of rat thoracic aorta
14. The role of tumor necrosis factor in the pathophysiology of heart failure
15. Levels of tumor necrosis factor (TNF-alpha) and interleukin 6 (IL-6) in serum of patients with acute myocardial infarction
16. Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure
17. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas
18. Ethanol potentiates interleukin-I beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells
19. Interaction of ethanol with inducible nitric oxide synthase messenger RNA and protein: Direct effects on autacoids and endotoxin in vivo
20. The potential mechanism of induction of inducible nitric oxide synthase mRNA in alveolar macrophages by lipopolysaccharide and its suppression by ethanol, in vivo
21. Differential regulation of inducible nitric oxide synthase gene expression by ethanol in the human intestinal epithelial cell line DLD-1
22. Ethanol modulates induction of nitric oxide synthase in glial cells by endotoxin
23. Ethanol inhibits inducible nitric oxide synthase transcription and post-transcriptional processes in vivo
24. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): Mechanisms of contractile depression by nitric oxide
25. S-Methylisothiourea sulfate improves renal, but not hepatic, dysfunction in canine endotoxic shock model
26. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: Evidence from pharmacological inhibition and gene knockout mice